Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2014-05-09 Share Issue/Capital Cha…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2014
Share Issue/Capital Change Classification · 99% confidence The document is a company announcement ("SELSKABSMEDDELELSE") dated May 9, 2014, detailing a specific corporate action: a directed share issue ('rettet emission') via debt conversion ('gældskonvertering') and the creation of a new class of shares ('ny aktieklasse'). This action directly impacts the company's capital structure and share issuance. This aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA), which covers new share issues and capital structure changes. It is not an earnings release, an annual report, or a simple announcement of a report release.
2014-05-09 English
Regulatory Filings 2014
Regulatory Filings
2014-05-09 Danish
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document is a formal announcement dated May 2, 2014, referencing a transaction (overdragelsesaftalen) and explicitly stating that the notification is made 'i henhold til værdipapirhandelslovens § 29' (according to the Securities Trading Act § 29). It details changes in share ownership percentages (16.78%) held by ALMC hf. and Baltic Investment Group ApS in Blue Vision A/S. This content directly relates to reporting changes in significant shareholdings, which corresponds to the definition of Major Shareholding Notification (MRQ). The document is short and serves as a direct notification, not a comprehensive report.
2014-05-02 Danish
M&A Activity 2014
M&A Activity Classification · 99% confidence The document is a formal announcement dated May 2, 2014, detailing a partial completion of a conditional transfer agreement concerning the sale of capital shares and the takeover of loan facilities in Blue Vision A/S. It discusses the acquisition of shares by Baltic Investment Group ApS, the status of remaining shares held by KIWI due to an existing pledge (Pantet), and the buyer's intention to seek dispensation from a mandatory takeover bid, which has been positively indicated by the Danish Financial Supervisory Authority (Finanstilsynet). This content strongly relates to corporate control, share ownership changes, and potential mandatory offers, fitting the description of a significant corporate transaction or change in control. Since it is an announcement about a transaction (sale/takeover) rather than a routine financial report (10-K, IR) or a director's trade (DIRS), the most appropriate category is M&A Activity (TAR), as it concerns the transfer of control/capital interests between major parties. Given the context of a takeover/acquisition process, TAR is the best fit over general regulatory filings (RNS). The document length is short (1907 chars), but it contains the substance of the transaction, not just a notice that a report is attached, thus ruling out RPA.
2014-05-02 Danish
AGM Information 2014
AGM Information Classification · 99% confidence The document text is a formal record (protokollat) detailing the agenda, proceedings, and resolutions passed during a general meeting, specifically mentioning the 'ordinær generalforsamling' (Annual General Meeting). Key elements include the election of a chairman ('dirigent'), the presentation and approval of the audited annual report ('årsrapport'), granting discharge to the board, voting on board remuneration, election of board members, and changes in management (CEO replacement). This content directly corresponds to the activities and documentation associated with an Annual General Meeting. Therefore, the classification is AGM-R.
2014-04-30 English
AGM Information 2014
AGM Information Classification · 100% confidence The document text is a formal record detailing the proceedings, agenda items, discussions, and resolutions passed during a general meeting of shareholders. Key indicators include the date, the mention of a 'dirigent' (chairman/moderator), the review of the 'Bestyrelsens beretning' (Board's report), approval of the audited annual report ('revideret årsrapport'), setting director fees, voting on profit/loss distribution, and the election/re-election of the board and auditor. This structure perfectly matches the definition of minutes or records from an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2014-04-30 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.